When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

NYT Connections hints today for #942: Clues and answers for Thursday, Jan. 8 WNBA CBA Deadline Looms, LSU Struggles, Unrivaled Tips Off & Te-Hina Paopao Joins Hoops 360 ...

Abstract: The solar array (SA) serves as the sole energy source for satellites, continuously converting sunlight into electricity to power satellite operations. Sensors placed at key locations on the ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Journal Sentinel beat writers break down Wisconsin's win over Marquette The Journal Sentinel's John Steppe and Ben Steele discuss Wisconsin's 96-76 win over Marquette, which was UW's biggest win in ...

The Journal Sentinel's John Steppe and Ben Steele discuss Wisconsin's 96-76 win over Marquette, which was UW's biggest win in the rivalry since 1952. Where is the public betting in Week 15 of the NFL ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

The Journal Sentinel's John Steppe discusses Wisconsin's 74-63 loss to TCU in the Rady Children's Invitational championship game. Jorge Polanco reportedly agrees to 2-year, $40 million deal with Mets ...

Journal Sentinel beat writers break down Wisconsin's win over Illinois The Journal Sentinel's Mark Stewart and John Steppe discuss some of their takeaways from the Badgers' 27-10 win over Illinois.